ICU Medical Inc (ICUI)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -117,688 | -29,655 | -74,286 | 103,135 | 86,870 |
| Total stockholders’ equity | US$ in thousands | 1,965,240 | 2,123,410 | 2,089,930 | 1,616,030 | 1,502,260 |
| ROE | -5.99% | -1.40% | -3.55% | 6.38% | 5.78% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $-117,688K ÷ $1,965,240K
= -5.99%
Based on the provided data, ICU Medical Inc's return on equity (ROE) has shown fluctuation over the years:
- As of December 31, 2020, the ROE was 5.78%, indicating that for each dollar of shareholders' equity, the company generated a profit of 5.78%.
- By December 31, 2021, ICU Medical Inc's ROE increased slightly to 6.38%, suggesting a modest improvement in the company's ability to generate profits from shareholders' equity.
- However, the trend reversed in the following years, with the ROE declining to -3.55% as of December 31, 2022. A negative ROE implies that the company was operating at a loss relative to its equity base.
- The downward trend continued in the subsequent years, with ROE figures of -1.40% as of December 31, 2023, and -5.99% as of December 31, 2024, indicating a worsening performance in terms of generating returns for shareholders.
In summary, ICU Medical Inc's ROE has been inconsistent, showing short-term improvements followed by declines and turning negative in recent years. This fluctuation in ROE signals varying levels of profitability and efficiency in utilizing shareholders' equity, which merits further investigation into the company's financial health and operational performance.
Peer comparison
Dec 31, 2024